Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate from ▲Subject
 25.4.2024CANDE s.r.o. (CRR-SK)6328CRENEMED 10 mg (tbl flm 100x10 mg (blis.PVC/Al))25.4.2024O
 25.4.2024N.V. Organon (ORG-NL)34008NASONEX (aer nau 1x18 g/140 dávok (fľ.HDPE s dávkovačom))25.4.2024O
 25.4.2024N.V. Organon (ORG-NL)22919Montelukast Organon 4 mg (tbl mnd 56x4 mg (blis.PA/Al/PVC))25.4.2024O
 25.4.2024CANDE s.r.o. (CRR-SK)3878DINOMED 500 mg tablety (tbl 50x500 mg (blis.PVC/PVDC/Al))25.4.2024O
 25.4.2024BELUPO, s.r.o. (BLU-SK)20379URUTAL 24 mg (tbl 50x24 mg (blis.PVC/PVDC/Al))25.4.2024R
 10.4.2024Teva B.V. (TEV-NL-4)28620Hylak forte (gto por 1x100 ml (liek.skl.hnedá))25.4.2024R
 23.4.2024Fresenius Kabi s.r.o. (FRK-CZ-3)10086Neodolpasse (sol inf 10x250 ml (fľ.skl.))25.4.2024O
 23.4.2024Fresenius Kabi s.r.o. (FRK-CZ-3)5279CSmofKabiven extra Nitrogen (emu inf 4x1012 ml (vak Biofin))25.4.2024O
 25.4.2024N.V. Organon (ORG-NL)39738Aerius 0,5 mg/ml perorálny roztok (sol por 1x60 ml/30 mg (fľa.skl.+plast.lyžica))25.4.2024O
 15.2.2024Teva B.V. (TEV-NL-4)23383Kyselina ibandrónová Teva 150 mg filmom obalené tablety (tbl flm 1x150 mg (blister PVC/Aclar/PVC-Al))25.4.2024R
 26.4.2024Teva B.V. (TEV-NL-4)8548CALGIFEN NEO (gto por 1x50 ml (fľ.skl.hnedá))25.4.2024O
 26.4.2024TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)37256Cabest 0,5 mg (tbl 8x0,5 mg (fľ.skl.hnedá))25.4.2024O
 24.4.2024Upjohn EESV (UPO-NL)62568Norvasc 10 mg tablety (tbl 30x10 mg (blis.PVC/PVDC/Al))24.4.2024O
 24.4.2024Neuraxpharm Bohemia s.r.o. (NUA)1492EZonisamide Neuraxpharm 50 mg tablety (tbl 56x50 mg (blis.PVC/Al))24.4.2024O
 24.4.2024Zentiva k.s. (ZNT-3)4699DXanirva 20 mg filmom obalené tablety (tbl flm 98x20 mg (blis.PVC/Al))24.4.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)